A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : APP / Actinobacillus pleuropneumoniae

[Related PubMed/MEDLINE]
Total Number of Papers: 85
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   APP  (>> Co-occurring Abbreviation)
Long Form:   Actinobacillus pleuropneumoniae
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A register-based study on associations between vaccination, antimicrobial use and productivity in conventional Danish finisher pig herds during 2011 to 2014. AMU, LAW, MYC, PCV2, PRRS, SPF
2019 Establishment and comparison of Actinobacillus pleuropneumoniae experimental infection model in mice and piglets. BALF, ICR, KM
2019 Global Gene Networks in 3D4/31 Porcine Alveolar Macrophages Treated with Antigenic Epitopes of Actinobacillus pleuropneumoniae ApxIA, IIA, and IVA. ---
2018 A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model. Apxr-OMV
2018 Actinobacillus pleuropneumoniae culture supernatant antiviral effect against porcine reproductive and respiratory syndrome virus occurs prior to the viral genome replication and transcription through actin depolymerization. PAMs, PRRSV, sgRNAs
2018 Actinobacillus pleuropneumoniae triggers IL-10 expression in tonsils to mediate colonisation and persistence of infection in pigs. ---
2018 Constitutive expression of antimicrobial peptide PR-39 in transgenic mice significantly enhances resistance to bacterial infection and promotes growth. Tg, WT
2018 Effective Pro-Inflammatory Induced Activity of GALT, a Conserved Antigen in A. Pleuropneumoniae, Improves the Cytokines Secretion of Macrophage via p38, ERK1/2 and JNK MAPKs Signal Pathway. ---
2018 Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71. ELISA, GalT, IHC
10  2018 Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics. API, FF, FIC, HCO, HPS, MIC, MRT, PKs, S. suis, SLN, TIL
11  2017 An anti-Propionibacterium acnes antibody shows heterologous resistance to an Actinobacillus pleuropneumoniae infection independent of neutrophils in mice. PA
12  2017 B cell cross-epitope of Propionibacterium acnes and Actinobacillus pleuropneumonia selected by phage display library can efficiently protect from Actinobacillus pleuropneumonia infection. CPP, PA
13  2017 Clinical Efficacy and Residue Depletion of 10% Enrofloxacin Enteric-Coated Granules in Pigs. AUC, BW, MS
14  2017 Detection of PR-39, a porcine host defence peptide, in different cell sub-linages in pigs infected with Actinobacillus pleuropneumoniae. PMNs
15  2017 Efficiency of different air filter types for pig facilities at laboratory scale. EAV, PRRSV
16  2017 Etiology of acute respiratory disease in fattening pigs in Finland. PCR, PCV2, PRCV, PRRSV, SIV
17  2017 Frequency of Th17 cells correlates with the presence of lung lesions in pigs chronically infected with Actinobacillus pleuropneumoniae. CCE, ICS
18  2017 Pig Lung Immune Cytokine Response to the Swine Influenza Virus and the Actinobacillus Pleuropneumoniae Infection. SIV
19  2017 Randomised controlled field study to evaluate the efficacy and clinical safety of a single 8mg/kg injectable dose of marbofloxacin compared with one or two doses of 7.5mg/kg injectable enrofloxacin for the treatment of Actinobacillus pleuropneumoniae infections in growing-fattening pigs in Europe. ---
20  2017 Transcript profiling of the immunological interactions between Actinobacillus pleuropneumoniae serotype 7 and the host by dual RNA-seq. DEGs
21  2016 Characterization of surfactant alterations in pigs infected with Actinobacillus pleuropneumoniae. ---
22  2016 Impact of Actinobacillus pleuropneumoniae biofilm mode of growth on the lipid A structures and stimulation of immune cells. PAMs
23  2016 Molecular serotyping and antimicrobial resistance profiles of Actinobacillus pleuropneumoniae isolated from pigs in South Korea. PCR, PP, RAPD
24  2016 The influence of Actinobacillus pleuropneumoniae infection on tulathromycin pharmacokinetics and lung tissue disposition in pigs. IM
25  2015 Erythema Multiforme Associated with Respiratory Disease in a Commercial Breeding Pig Herd. EM, PRRSV
26  2015 Pharmacokinetics of tulathromycin in edible tissues of healthy and experimentally infected pigs with Actinobacillus pleuropneumoniae. AUC, BW
27  2015 The challenge of detecting herds sub-clinically infected with Actinobacillus pleuropneumoniae. ---
28  2014 Actinobacillus pleuropneumoniae challenge in swine: diagnostic of lung alterations by infrared thermography. CT, IRT
29  2014 Actinobacillus pleuropneumoniae possesses an antiviral activity against porcine reproductive and respiratory syndrome virus. MOI, PAM, PRDC, PRRSV
30  2014 Actinobacillus pleuropneumoniae seroprevalence in farmed wild boars in Finland. CI
31  2014 Acute and subacute response of iron, zinc, copper and selenium in pigs experimentally infected with Actinobacillus pleuropneumoniae. APR, Cp, Hb, PCV, Se, Zn
32  2014 Association of swine influenza H1N1 pandemic virus (SIV-H1N1p) with porcine respiratory disease complex in sows from commercial pig farms in Colombia. HA, MDCK, Myh, OR, PCV2, PRDC, PRRSV, SIV, SIV-H1N1p
33  2014 Comparison of four lung scoring systems for the assessment of the pathological outcomes derived from Actinobacillus pleuropneumoniae experimental infections. ADWG, IA, LLS, LW/BW, SPES
34  2014 Effect of bovine apo-lactoferrin on the growth and virulence of Actinobacillus pleuropneumoniae. LF
35  2014 Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations. CFR, HP, MIC, MPC, PK/PD, PTA
36  2013 Distribution of porcine monocytes in different lymphoid tissues and the lungs during experimental Actinobacillus pleuropneumoniae infection and the role of chemokines. BM, PB
37  2013 Transcriptional profiling of hilar nodes from pigs after experimental infection with Actinobacillus pleuropneumoniae. BP, DB, DE, HN, PP, TG
38  2012 Bacterial pathogens associated with lung lesions in slaughter pigs from 125 herds. HPS, Mhp, PCR, PM
39  2012 Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs following vaccination or experimental challenge with respiratory pathogens and natural A. pleuropneumoniae serovar 1 challenge. ELISAs
40  2012 Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida. ELISAs
41  2012 Experimental Actinobacillus pleuropneumoniae challenge in swine: comparison of computed tomographic and radiographic findings during disease. CT
42  2012 Genetic variability in swine leukocyte antigen class II and Toll-like receptors affects immune responses to vaccination for bacterial infections in pigs. ER, SLA, TLR
43  2012 Magnetic beads-based enzymatic spectrofluorometric assay for rapid and sensitive detection of antibody against ApxIVA of Actinobacillus pleuropneumoniae. ApxIVA, HRP, LOD, RSD
44  2012 Profiling microRNAs in lung tissue from pigs infected with Actinobacillus pleuropneumoniae. miRNAs
45  2011 Immunoproteomic analysis of bacterial proteins of Actinobacillus pleuropneumoniae serotype 1. ---
46  2010 Antibiotic susceptibility of bacteria isolated from respiratory tract of pigs in Poland between 2004 and 2008. A. pyogenes, E. coli, HPS, PM, S. suis
47  2010 Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice. APP1, ApxI, ApxII, ApxIII, apxIV, IIF, OMP, PBS, PCP, rApfa, rApxI, rApxII, rApxIII, rApxIV, rOMP
48  2010 Porcine mononuclear phagocyte subpopulations in the lung, blood and bone marrow: dynamics during inflammation induced by Actinobacillus pleuropneumoniae. BM, MP, PB
49  2010 Risk factors associated with pleuritis and cranio-ventral pulmonary consolidation in slaughter-aged pigs. Mhyo, PRRSV, SIV
50  2009 Screening of strain-specific Actinobacillus pleuropneumoniae genes using a combination method. RDA
51  2009 [Interaction between Actinobacillus pleuropneumoniae RTX toxin and host--a review]. ---
52  2008 Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model. ---
53  2008 Gold(III) enhanced chemiluminescence immunoassay for detection of antibody against ApxIV of Actinobacillus pleuropneumoniae. CL, CLIA, ELISA, IHA
54  2008 [Study of the virulence of Actinobacillus pleuropneumoniae in finishing pigs as a basis for vaccination development]. CFU
55  2007 A successful national control programme for enzootic respiratory diseases in pigs in Switzerland. EP
56  2006 A serological survey of selected pathogens in wild boar in Slovenia. ADV, ELISA, HPS, PPV, PRCV
57  2006 [Acute toxicity and immunoprotection of recombinant apxI toxin of Actinobacillus pleuropneumoniae in mice]. ---
58  2006 [Study on immunogenicity of the N-terminal polypeptide of RTX toxin I of Actinobacillus pleuropneumoniae]. nApxI
59  2005 Experimental Actinobacillus pleuropneumoniae infection in piglets with different types and levels of specific protection: immunophenotypic analysis of lymphocyte subsets in the circulation and respiratory mucosal lymphoid tissue. BALF, TLN
60  2005 Systemic and local antibody responses after experimental infection with Actinobacillus pleuropneumoniae in piglets with passive or active immunity. BALF, IgG
61  2005 [Development and application of multiplex-PCR for identification of Actinobacillus pleuropneumoniae]. PCR
62  2004 Analysis of differential protein expression in Actinobacillus pleuropneumoniae by Surface Enhanced Laser Desorption Ionisation--ProteinChip (SELDI) technology. BHI, SELDI
63  2004 Evaluation of PCR based on gene apxIVA associated with 16S rDNA sequencing for the identification of Actinobacillus pleuropneumoniae and related species. ---
64  2004 Impairment of oxidative burst in porcine neutrophils induced by pseudorabies virus. NADPH, OB, PMA, PRV
65  2003 Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. dpi, M. hyopneumoniae, PCV2, PMWS
66  2003 In vitro effects of Actinobacillus pleuropneumoniae on inducible nitric oxide synthase and cyclooxygenase-2 in porcine alveolar macrophages. COX-2, iNOS, LPS, NO, PGE2
67  2003 Purification and binding properties of porcine plasma ficolin that binds Actinobacillus pleuropneumoniae. ---
68  2003 [Cloning and expression of the apx III A gene of Actinobacillus pleuropneumonie]. ---
69  2002 Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan. ---
70  2002 Influence of porcine Actinobacillus pleuropneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin. ---
71  2001 A comparative study of the preventive use of tilmicosin phosphate (Pulmotil premix) and Mycoplasma hyopneumoniae vaccination in a pig herd with chronic respiratory disease. ADG, CMD, FCR, Mh, PRRSV
72  2001 In vitro migratory responses of swine neutrophils to actinobacillus pleuropneumoniae. PBMC, PRV
73  2001 The transferrin receptor of Actinobacillus pleuropneumoniae: quantitation of expression and structural characterization using a peptide-specific monoclonal antibody. ELISA, Tbps
74  2000 Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. DC
75  2000 Simultaneous serological evidence of Actinobacillus pleuropneumoniae, PRRS, Aujeszky's disease and influenza viruses in Spanish finishing pigs. ADV, PRRSV, SIV
76  1998 Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination. Apx
77  1997 Characterization of a large transferrin-binding protein from Actinobacillus pleuropneumoniae serotype 7. ---
78  1997 Dual infections of PRRSV/influenza or PRRSV/Actinobacillus pleuropneumoniae in the respiratory tract. PRRS, SPF
79  1996 Immunohistological evaluation on respiratory lesions of pigs intranasally inoculated with Actinobacillus pleuropneumoniae serotype 1. p.i
80  1995 Effect of physical defenses of the respiratory tract on the development of pneumonia in pigs inoculated endobronchially with Actinobacillus pleuropneumoniae. CFU
81  1994 Effect of passive immunization with serotype-specific monoclonal antibodies on Actinobacillus pleuropneumoniae infection of mice. LPS, MoAbs
82  1994 Efficacy of an Actinobacillus pleuropneumoniae bacterin against serotypes 1, 3, 5 and 9. ---
83  1994 Functional and structural changes of porcine alveolar macrophages induced by sublytic doses of a heat-labile, hemolytic, cytotoxic substance produced by Actinobacillus pleuropneumoniae. ---
84  1993 The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison. ---
85  1992 Variation in seropositivity for some respiratory disease agents in finishing pigs: epidemiological studies on some health parameters and farm and management conditions in the herds. ADV, PI